Pages that link to "Q24600512"

The following pages link to Metabolism of kidney cancer: from the lab to clinical practice (Q24600512):

Displaying 36 items.

• A Diet Diverse in Bamboo Parts is Important for Giant Panda (Ailuropoda melanoleuca) Metabolism and Health (Q33794122) (← links)
• Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma (Q34436020) (← links)
• Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis (Q35122474) (← links)
• Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach (Q36646189) (← links)
• Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response (Q37180374) (← links)
• Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. (Q37421650) (← links)
• The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy (Q37576212) (← links)
• Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma (Q37660323) (← links)
• Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma (Q37681761) (← links)
• Precision medicine for metastatic renal cell carcinoma (Q38163227) (← links)
• Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networks (Q38467844) (← links)
• NMR metabolomics of renal cancer: an overview (Q38591205) (← links)
• (1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism. (Q38815713) (← links)
• Therapeutic Strategies for Hereditary Kidney Cancer (Q38871343) (← links)
• Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression (Q38900577) (← links)
• The metabolomics and lipidomics window into thyroid cancer research (Q38996666) (← links)
• De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study (Q39735678) (← links)
• Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells (Q41329894) (← links)
• Geriatric Nutrition Risk Index is an Important Predictor of Cancer-Specific Survival, but not Recurrence-Free Survival, in Patients Undergoing Surgical Resection for Non-Metastatic Renal Cell Carcinoma (Q41971161) (← links)
• Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma (Q42293369) (← links)
• ccRCC is fundamentally a metabolic disorder. (Q43207128) (← links)
• Expression of sodium-dependent dicarboxylate transporter 1 (NaDC1/SLC13A2) in normal and neoplastic human kidney. (Q48018871) (← links)
• Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. (Q49554294) (← links)
• The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma (Q50050970) (← links)
• Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. (Q51737515) (← links)
• Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma. (Q52899766) (← links)
• Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma. (Q55370445) (← links)
• Non-Invasive Assessment of Lactate Production and Compartmentalization in Renal Cell Carcinomas Using Hyperpolarized C Pyruvate MRI (Q57160517) (← links)
• Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions (Q58104083) (← links)
• The Metabolism of Renal Cell Carcinomas and Liver Cancer (Q60628580) (← links)
• Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma (Q64079978) (← links)
• The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy (Q64237577) (← links)
• Diagnosis and Management of Hereditary Renal Cell Cancer (Q89178465) (← links)
• Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients (Q92542015) (← links)
• The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma (Q93102798) (← links)
• A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma (Q98184172) (← links)